SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJourneo Regulatory News (JNEO)

Share Price Information for Journeo (JNEO)

Share Price is delayed by 15 minutes
Get Live Data
440.00    15.00 (3.53%)
Bid:
430.00
Ask:
450.00
Spread: 20.00 (4.651%)
Market Cap: £77.77m
JNEO Live PriceLast checked at - London Stock Exchange

Intraday Journeo Share Chart

Director Share Purchases

27 Mar 2024 10:33

RNS Number : 5228I
Journeo PLC
27 March 2024
 

27 March 2024

 

Journeo plc

("Journeo" or the "Company")

 

Director Share Purchases

 

Journeo plc (AIM: JNEO), a leading provider of information systems and technical services to transport operators and local authorities, announces that Nick Lowe, Chief Financial Officer, has purchased 8,800 ordinary shares of 6.5p each in the Company ("Ordinary Shares") at a volume weighted average price of approximately 282.25p pence per Ordinary Share.

 

Following these purchases, Mr Lowe holds a total beneficial interest in 43,800 Ordinary Shares representing approximately 0.27 per cent. of the Company's issued share capital. Further detail is set out below.

 

 

For further information please contact:

 

Journeo plc 

Russ Singleton, Chief Executive Officer

Nick Lowe, Chief Financial Officer

 +44 (0) 203 651 9166

 

Cavendish Capital Markets Limited

Nominated Adviser and Broker Katy Birkin / Callum Davidson

+44 (0) 207 220 0500

 

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Nick Lowe

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Journeo plc

b)

LEI

213800TKF7L4IEV9W867

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of 6.5 pence each

Identification code

GB00BKP51V79

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volumes(s)

Date

Volume(s)

Price(s)

26 / 03 / 24

5,000

281.89p

26 / 03 / 24

1,000

283.366p

27 / 03 / 24

2,800

282.5p

d)

Aggregated information

Aggregated volume

8,800

Price

Volume weighted average price of 282.25p

e)

Date of the transaction

26 March 2024 and 27 March 2024

f)

Place of the transaction

AIMX

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBDLFLZXLXBBF
Date   Source Headline
26th May 20262:10 pmRNSHolding(s) in Company
7th May 20261:19 pmRNSHolding(s) in Company
7th May 20267:00 amRNSUS$1.2 million Purchase Order
28th Apr 202611:54 amRNSResult of AGM
23rd Apr 20267:00 amRNS£1.0m Infrastructure Protection Contracts
13th Apr 20267:00 amRNS£1.7m Purchase Orders for Information Systems
31st Mar 20267:00 amRNS£2.4m Contract Awards – Infrastructure Protection
24th Mar 20267:00 amRNSFinal Results
19th Mar 20267:00 amRNSNotice of Results and Investor Presentation
16th Mar 20267:00 amRNS-RContract award in Denmark
16th Mar 20267:00 amRNS-RContract award in Denmark
21st Jan 20267:00 amRNSTrading Update
12th Jan 20267:00 amRNSPurchase Orders
8th Dec 20257:00 amRNS£2.3m Purchase Orders – Infrastructure Protection
1st Dec 20254:25 pmRNSOption Exercise, Issue of Equity & PDMR Dealings
29th Oct 20257:00 amRNS$5m purchase orders for New York Subway
15th Oct 20254:02 pmRNSOption Exercise, Issue of Equity & PDMR Dealings
10th Oct 20259:45 amRNSHolding(s) in Company
30th Sep 20257:00 amRNSPurchase Orders
25th Sep 20257:00 amRNSHalf-year Report
18th Sep 20257:00 amRNSPurchase Order
8th Sep 20257:00 amRNS-RNotice of Results & Investor Presentation
8th Sep 20257:00 amRNSFramework Agreement
2nd Sep 20257:00 amRNSAcquisition of Crime and Fire Defence Systems
1st Sep 20257:00 amRNS£3.5m Framework Agreement
27th Aug 20257:00 amRNS£1m Purchase Orders and airport systems extension
29th Jul 20257:00 amRNSTrading Update
16th Jul 20257:00 amRNS-RContract award in Denmark
10th Jul 20252:28 pmRNSHolding(s) in Company
19th Jun 20257:00 amRNSPurchase Order
5th Jun 20252:09 pmRNSDirector/PDMR Shareholding
29th May 20257:00 amRNS£4.2m Rail Systems Purchase Order
14th May 20257:00 amRNS£10m Framework Agreement
23rd Apr 202512:30 pmRNSResult of AGM
16th Apr 20257:00 amRNSPurchase Order
26th Mar 20259:54 amRNSDirector/PDMR Shareholding
25th Mar 20257:00 amRNSFinal Results
21st Mar 20253:08 pmRNSHolding(s) in Company
20th Mar 20257:00 amRNSNotice of Results & Investor Presentation via IMC
18th Feb 202510:55 amRNSHolding(s) in Company
31st Jan 202511:09 amRNSHolding(s) in Company
29th Jan 20254:52 pmRNSIssue of Equity
29th Jan 202511:33 amRNSHolding(s) in Company
23rd Jan 202510:55 amRNSHolding(s) in Company
23rd Jan 20257:00 amRNSIssue of Equity and PDMR Dealings
20th Jan 20257:00 amRNSPurchase Order
14th Jan 20257:00 amRNSTrading Update
10th Jan 202511:16 amRNSHolding(s) in Company
7th Jan 20257:00 amRNSContract Award
17th Dec 20241:13 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.